Precision Oncology for Therapies of Tomorrow
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address the unmet clinical need in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), and other hematologic malignancies.